Human immunocompetent Organ-on-Chip platforms allow safety profiling of tumor-targeted T-cell bispecific antibodies
Safety Profiling of Tumor-targeted T Cell-Bispecific Antibodies with Alveolus Lung- and Colon-on-Chip
CanChip GmbH
We are a commercial provider of a microphysiological system either as a product or service.
Changes in generations of PAMAM dendrimers and compositions of nucleic acid nanoparticles govern delivery and immune recognition
A dynamic microscale mid-throughput fibrosis model to investigate the effects of different ratios of cardiomyocytes and fibroblasts
TheWell Bioscience
TheWell Bioscience provides xeno-free, 3D cell culture solutions, empowering research in organoids, regenerative medicine, and drug discovery.
VoxCell BioInnovation
VoxCell BioInnovation is a forward-thinking biotechnology company specializing in 3D, vascularized bioprinted tissue models for preclinical drug screening. Using high-resolution bioprinting, trade vascularization software, and Universal Bioinks™, VoxCell creates human-like tumor models that mimic the tumor microenvironment, enhancing drug testing accuracy.
Bioprinting Laboratories
Bioprinting Labs’ pillar/perfusion plates enable robust and reproducible organoid culture and in situ analysis. Our products streamline organoid-based assays by facilitating miniature organoid culture and enhancing organoid maturity through dynamic culture in the pillar/perfusion plates.
AIM Biotech
AIM Biotech is a leading bioengineering company, offering scalable, cost-effective 3D cell culture platforms, drug screening services, and customized assay development. By combining model realism and platform simplicity, AIM’s plug-and-play technologies empower drug developers to mimic human biology with precision, delivering clinically-relevant data.